Overview

Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of Hemospan infusion on vascular reactivity, regional perfusion and oxygenation of ischemic tissue in patients with chronic critical lower limb ischemia.
Phase:
Phase 2
Details
Lead Sponsor:
Sangart
Treatments:
Hydroxyethyl Starch Derivatives
Pharmaceutical Solutions